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Abstract
Background: Consensus guidelines published in 2016 recommended a 2 mm free
margin as the standard for negative margins in patients undergoing breast-conserving
surgery (BCS) for ductal carcinoma in situ (DCIS). The goal of the guideline recommendation was standardization of re-excision practices.
Aims: To evaluate the impact of this consensus guideline on our institutional
practices.
Methods: We identified all patients at our institution with pure DCIS who were initially treated with BCS from September 2014 to August 2018 using a prospectivelymaintained institutional database. A retrospective chart review was performed to
determine margin status and re-excision rates during the 2 years before and the
2 years after the guideline was published in order to determine the effect on our reexcision rates. Close margins were defined as <2 mm.
Results: In the 2 years before the consensus guideline was published, 184 patients with
DCIS underwent BCS. Twenty-six patients had positive margins and 24 underwent reexcision, including three who had completion mastectomy. Of the remaining 159 patients,
76 had ≥2 mm (negative) margins. The remaining 82 patients had close margins and
48 of these patients (58.5%) underwent re-excision, including one who had a completion
mastectomy. Excluding the patients with positive margins, our re-excision rate was
30.4% prior to the guideline. In the 2 years after the consensus guideline was published,
192 patients with DCIS underwent initial BCS. Twenty-four patients had positive margins
and 22 underwent re-excision, including three who had completion mastectomy. Of the
remaining 168 patients, 95 patients had ≥2 mm (negative) margins. The remaining
73 patients had close margins and 45 of those patients (61.6%) underwent re-excision,
including six who had completion mastectomy. Excluding the patients with positive margins, our re-excision rate was 26.8% after the guideline.
Conclusions: Our institution's re-excision rate did not change significantly during the
2 years before and after the publication of the consensus guideline on adequate margins for patients undergoing BCT for DCIS. Our overall re-excision rate decreased
slightly. However, of the patients who had close margins, a larger proportion underwent re-excision after the guideline was published. The guideline publication appears
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to have affected our institutional practices slightly, but not dramatically as many of
our surgeons' practices were comparable to the guideline recommendations prior to
2016. We continue to use clinical judgment based on patient and tumor characteristics in deciding which patients will benefit from margin re-excision.
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I N T RO DU CT I O N

The approach to the treatment of breast cancer is an ever-evolving

2
2.1

METHODS

|
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Study population

field. The days of the Halsted radical mastectomy have long since
been replaced with less invasive surgical options, including breast con-

Approval was obtained from the institutional review board at

servation surgery (BCS). A key component of BCS is obtaining ade-

Washington University in St. Louis. Utilizing a prospectively

quate surgical margins so as to decrease the risk of ipsilateral breast

maintained institutional database, all patients 18 years and older with

tumor recurrence (IBTR).1,2 Margin status for DCIS poses a unique

a diagnosis of pure DCIS (no invasive component) undergoing BCS

challenge for the clinician due to the nature of the disease itself. DCIS

from September 2014 to August 2018 were identified. Only patients

often presents as a non-palpable lesion identified as calcifications on

whose initial surgery was performed at Barnes Jewish Hospital/

screening mammography, and it can be multi-focal with areas of nor-

Siteman Cancer Center were analyzed. Patients were excluded if they

mal ductal tissue between affected ductal segments.3,4 For these rea-

had their index surgical procedure at an outside institution.
Patients were divided into two groups based on the date of their ini-

sons, the re-excision rates have been reported as high as 70%, with an
average re-excision rate for DCIS around 30%–40%.4–7
For many years, there was no clear definition of adequate margins

tial surgical procedure being before or after September 2016, when the
SSO-ASTRO-ASCO guideline would have been adopted by our institution.

for BCS. This resulted in variable practice patterns among providers
across the country and within communities, and variable re-excision
rates.8,9 In 2014, the Society of Surgical Oncology (SSO) and American

2.2

|

Data analysis

Society of Radiation Oncology (ASTRO) published a consensus guideline
on adequate margins for BCS with adjuvant whole breast irradiation

A retrospective chart review was performed to obtain demographic, clini-

(WBI) in patients with early stage invasive breast cancer. This statement

cal, and pathologic data from our electronic medical record. During the

recommended no ink on tumor as the standard for negative margins.

study period, six surgeons were practicing at our institution, at four dif-

These conclusions were based on a meta-analysis of 33 studies includ-

ferent surgical centers, all sharing the same electronic medical record and

ing 28 162 patients, performed by a multi-disciplinary expert panel,

institutional database. Surgical specimens were marked intraoperatively

demonstrating no significant difference in IBTR for more widely clear

by the surgical team using a short stitch superiorly and a long stitch later-

margins.10

ally. The breast pathology team then inked and processed the specimens

Similar guidelines were published in 2016 for DCIS, recommending

according to institutional protocols. The final pathology reports were

2 mm margins for BCS with planned adjuvant WBI. This guideline was

reviewed to determine margin status on all index and re-excision proce-

released by the SSO, ASTRO, and the American Society of Clinical

dures. Margins were defined as negative if they were ≥2 mm from the

Oncology (ASCO). Once again, a multi-disciplinary expert panel con-

tumor, close if they were within 2 mm of the tumor, and positive if there

ducted a meta-analysis of 20 studies including 7883 patients, demon-

was ink on the tumor. It is important to note that our institutional defini-

strating an optimal margin width of 2 mm to reduce the risk of IBTR.

tions of negative, close, and positive margins were ultimately the same

They also recommended the use of clinical judgment in determining the

as the guideline definition of these margins.

need for re-excision in patients with negative margins less than 2 mm.11

For each group, overall re-excision rates were calculated as the

Both of these society guidelines sought to standardize re-excision

percentage of patients undergoing any type of re-excision procedure

practices for BCS in order to reduce re-excision rates and their subse-

(including mastectomy) out of the total number of patients undergoing

quent effects on patient outcomes while minimizing the risk of

initial BCS. Re-excision rates were similarly calculated for the sub-

IBTR.10,11 We previously reported on the potential impact of the

groups of patients with close margins, with positive margins, and with

2014 guideline on our institution's practice, with an estimated reduc-

non-positive margins (i.e. excluding those with positive margins). Simi-

tion of over 5% in re-excision rates for invasive disease.12 We now

lar calculations were also performed after excluding those patients

analyze the impact of the 2016 guideline at our institution by evaluat-

who did not have a pre-operative diagnosis of DCIS but were found

ing re-excision rates before and after the publication of the consensus

to have DCIS on final pathology. We defined the “true re-excision

guideline for DCIS.

rate” as the re-excision rates excluding those patients who underwent
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T A B L E 1 Patient demographics and
tumor characteristics

Variable

Pre-guideline n = 184

Post-guideline n = 192

p values

Mean age

60

59

p = .27
p = .19

Race
Caucasian

125

129

-

Black/African American

53

52

-

Asian

6

11

p = .45

Hormone receptor status
ER+

166

169

-

ER

15

12

-

Unknown

3

11

p = .11

Tumor grade
1

41

32

-

2

89

78

-

3

54

82

-

excisional biopsies as the initial surgical procedure. Of note, positive

(A)

posterior margins and positive anterior margins are routinely not reexcised at our institution if the surgeon has documented resection to
the pectoralis fascia or sub-dermis, respectively. Statistical analyses
were performed using a Fisher's exact test for re-excision rates.

3
3.1

RESULTS

|
|

Study population
(B)

A total of 376 patients underwent initial BCS at our institution for
pure DCIS during the four-year study period. 184 of these patients
had their initial surgery between September 2014 and August 2016,
during the 2 years before the SSO-ASTRO-ASCO guideline was
adopted by our institution. The remaining 192 patients had their initial
surgery during the 2 years following the guideline adoption, from
September 2016 to August 2018. Patient demographics and tumor
characteristics were similar between the two groups (Table 1).

3.2 | Pre-guideline (September 2014 through
August 2016)

F I G U R E 1 (A) Pre-guideline index procedure margin status and
re-excisions. (B) Post-guideline index procedure margin status and reexcisions

Of the 184 patients in the pre-guideline cohort, 76 patients (41.3%)

review. Excluding the patients with positive margins, our re-excision

had negative margins, 26 (14.1%) had positive margins, and

rate was 30.4%. This cohort included 43 patients who underwent

82 (44.6%) had close margins on initial excision. There were 8 patients

excisional biopsy and were upgraded to a diagnosis of DCIS on final

who underwent an oncoplastic surgical technique with combined

pathology. If we exclude these patients and calculate the re-excision

reduction mammoplasty and all had negative margins. Twenty-four of

rates for only those patients with a pre-operative diagnosis of DCIS,

the patients with positive margins (92.3%) and 48 of the patients with

our true re-excision rate was 32.6% (Figure 1A and Table 2).

close margins (58.5%) underwent re-excision, for an overall re-

Twenty-nine patients (40.3%) had residual DCIS identified on

excision rate of 39.1%. Patients with positive margins who did not

re-excision. One patient had a second re-excision procedure for per-

undergo re-excision had either positive posterior or anterior margins

sistently close or positive margins. Four patients ultimately had a

and the surgeon felt that they had resected to the pectoralis fascia or

mastectomy performed on subsequent excisions (three on the first re-

sub-dermis, respectively. The reasons why patients with close margins

excision procedure and one on the second re-excision). Details are

were not re-excised was difficult to ascertain from the retrospective

displayed in Table 3.
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TABLE 2

TREMELLING ET AL.

Re-excision rates

Overall
Of close margins

Pre-guidelines n = 184

Post-guidelines n = 192

p values

72/184 (39.1%)

67/192 (34.9%)

p = .48

48/82 (58.5%)

45/73 (61.6%)

p = .34

24/26 (92.3%)

22/24 (91.7%)

p = .51

Excluding positive margins (Of non-positive margins)

48/158 (30.4%)

45/168 (26.8%)

p = .27

True overall re-excision rate (Excluding excisional
biopsies)

46/141 (32.6%)

46/157 (29.3%)

p = .43

Of positive margins

TABLE 3

Re-excision procedure outcomes

excision procedure and three on the second re-excision). Details are

Pre-guidelines

Postguidelines

Residual DCIS on re-excision

29/72 (40.3%)

27/67 (40.3%)

Second re-excision procedure

1

7

Mastectomy on subsequent
excision

4

9

displayed in Table 3.
At a mean follow-up of 3.1 years, there have been no recurrences
in the post-guideline cohort.
All p values demonstrated no significant difference in the reexcision rates in the pre- and post-guideline cohorts (Table 2).

4

|

DI SCU SSION

At a mean follow-up of 4.2 years, there have been 3 IBTRs in the
pre-guideline cohort. Two of these patients had an invasive recur-

BCS has become the preferred surgical option in the surgical treat-

rence, while the third patient had a new/recurrent DCIS. All three

ment of breast cancer for patients with early disease. However, the

were patients who had initial positive margins and underwent re-

definition of clear margins for BCS has been one of contention since

excision at the initial diagnosis. One additional patient in the pre-

its introduction. With the development of consensus guidelines in

guideline cohort experienced a new contralateral invasive breast can-

2014 and 2016 on margin recommendations for BCS, there are now

cer during follow-up.

well-defined recommendations to aid in clinical decision making
regarding re-excision.
Although there were no significant differences in the rates of re-

3.3 | Post-guideline (September 2016 through
August 2018)

excision before and after the 2016 guideline was adopted, our overall
re-excision rate trended down. Our re-excision rates trended up for
margins that were negative but less than 2 mm (close) before and after

Of the 192 patients in the post-guideline cohort, 95 patients (49.5%)

the guideline adoption (58.5% and 61.6%, respectively). Based on these

had negative margins, 24 (12.5%) had positive margins, and 73 (38%)

findings, we conclude that our practice patterns for re-excising margins

had close margins on initial excision. There were 13 patients who

in BCS for pure DCIS from 2014 to 2016 were already similar to the

underwent an oncoplastic surgical technique with combined reduction

guideline recommendations. This is further supported by the fact that

mammoplasty and all had negative margins. Twenty-two of the

we did not see any re-excisions for margins greater than 2 mm in the

patients with positive margins (91.7%) and 45 of the patients with

pre-guideline group, again demonstrating that we were already using a

close margins (61.6%) underwent re-excision, for an overall re-

margin threshold of 2 mm in most circumstances.

excision rate of 34.9%. Patients with positive margins who did not

At our institution, individual cases are presented at a weekly

undergo re-excision had either positive posterior or anterior margins

multi-disciplinary tumor board where we review the patient's images

and the surgeon felt that they had resected to the pectoralis fascia or

and pathology slides and discuss management recommendations. This

sub-dermis, respectively. The reasons why patients with close margins

venue is often used to discuss adequacy of margins and the need for

were not re-excised was difficult to ascertain from the retrospective

additional surgery based on the patient's age, life expectancy, co-mor-

review. Excluding the patients with positive margins, our re-excision

bidities, extent of disease, cosmetic outcome, and risk of recurrence.

rate was 26.8%. This cohort included 35 patients who underwent

We have in the past used, and continue to use, clinical judgment to

excisional biopsy and were upgraded to a diagnosis of DCIS on final

determine if an individual patient will benefit from margin re-excision.

pathology. Excluding those patients, our true re-excision rate was
29.3% (Figure 1B and Table 2).

In both groups, all patients with positive margins that did not
undergo re-excision had documentation for the reason no re-excision

Twenty-seven patients (40.3%) had residual DCIS identified on

was performed (i.e. margin at the level of the skin or pectoralis fascia,

re-excision. Seven patients had a second re-excision procedure for

focally positive margin, and no residual calcifications on mammogram).

persistently close or positive margins. Nine patients ultimately had a

For patients with close margins that were not re-excised, we found sim-

mastectomy performed on subsequent excisions (six on the first re-

ilar documentation in 4 of the 35 patients (11.4%) in the pre-guideline
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cohort, and in 8 of the 28 patients (28.6%) in the post-guideline cohort.

DATA AVAILABILITY STAT EMEN T

This demonstrates that although we may have followed similar prac-

The data is available upon request.

tices before the guideline publication, our documentation in support of
our clinical decision-making began to improve.
The strengths of our study are in our patient population and
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DCIS found on excisional biopsy in our subgroup analysis, we were
able to determine our true re-excision rates for those patients whose
initial surgery had the intent of obtaining clear margins.
Our study is limited as it is a retrospective review from a single
institution. Additionally, we did not account for variability in practice
patterns between individual surgeons at our institution, such as operative technique and personal differences in re-excision thresholds. For
example, the use of selective versus routine cavity shave margins during the study period varied among surgeons. These practices may
have affected re-excision rates between surgeons, but likely would
have been the same in the pre- and post-guideline cohorts.
In conclusion, our findings demonstrate that our institution's practice patterns were similar during the 2 years before and after the publication of the 2016 SSO-ASTRO-ASCO consensus guideline on
margins in BCS for patients with DCIS. Our re-excision rates did
decline slightly, and we continue to use clinical judgment based on
patient and tumor characteristics in deciding which patients will benefit from margin re-excision. Despite the current consensus guidelines,
margin status will continue to be an area of debate and research in
BCS as we try to find the optimal balance between less surgery and
minimizing the risk of local recurrence.
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